last year 24.2%. The Company’s 6-month end net profit margin stood at 25.9%. An increase of net profit was a result of the Company has higher revenues from collection of purchased accounts receivables
84.69 75.27 Total revenues of the Company and the Company’s subsidiaries in the consolidated financial statements for the year end period of December 31, 2017 was THB 540.98 million, an increase of THB 29
equaled 449.0 million baht, which was an increase from the same period for the previous year by 69.7 million baht or an increase of 18.4 percent. While the Company’s total income for the 6-month end was
the parent) of Baht 258 million and earnings per share of Baht 0.13 for 1Q2018, an increase of 14% when compared to consolidated profits (attributable to equity holders of the parent) of Baht 226
the Company’s subsidiaries in the consolidated financial statements for the 9 months period end of September 30, 2017 was THB 403.05 million, an increase of THB 21.28 million or 5.57% from the same
available-for-sale of 2.37 million baht, an increase of 0.33 million baht or 15.92% as share value increased at the end of the quarter. According to Q2/2017 performance, the company has a strong financial
years ending 31 December 2017 and 2018, the Group’s total revenue increased from THB 2,515.2 Mn in 2017 to THB 2,964.7 Mn in 2018, an increase of THB 449.5 Mn or 17.9%. This was mainly due to increased
provision to support the new accounting policy change in 2019. Financial Position Overview As of the end of the second quarter of 2017, the Company had 36,287.75 million Baht in total assets, an increase of
Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 31st March 2019 as follows. Summary